Loading clinical trials...
Loading clinical trials...
Assess the Effect of DHEA or Other Androgenic Agents on Ovarian Reserve Markers in Women With Diminished Ovarian Reserve
Conditions
Interventions
DHEA
Another Androgenic Agent (VRaA)
+1 more
Locations
1
Chile
Mother and Health Research Institute (IDIMI), Faculty of Medicine, University of Chile
Santiago, International, Chile
Start Date
July 15, 2014
Primary Completion Date
August 31, 2016
Completion Date
August 31, 2016
Last Updated
May 29, 2019
NCT07499804
NCT06826365
NCT04872660
NCT07439458
NCT06984081
NCT05837325
Lead Sponsor
Laboratorios Andromaco S.A.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions